Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

NCT00094653

Conditions
Melanoma, Metastases, Neoplasm Metastasis, +14 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • University Medical Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • San Diego Cancer Center Encinitas, California, United States
View all 209 locations
View Trial Details
Completed

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

Conditions
Malignant Melanoma, Melanoma, Metastatic Melanoma, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

NCT00600054

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +16 more
Locations
  • Children's Hospital/University of Colorado Denver, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

NCT00089427

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +17 more
Locations
  • University of California San Francisco - Dept. of Neurological Surgery San Francisco, California, United States
  • Carolina Neurosurgery & Spine Assoc. Charlotte, North Carolina, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Cleveland Clinic Foundation Department of Neurological Surgery Cleveland, Ohio, United States
View Trial Details
Completed

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

NCT00098761

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +26 more
Locations
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00780663

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
Locations
  • Birmingham Hematology and Oncology Birmingham, Alabama, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Ocala, Florida, United States
View all 13 locations
View Trial Details

Related conditions